Ms Susan Darnell Turner Iv, | |
256 School Street, Betsy Layne, KY 41605-0128 | |
(606) 478-9751 | |
Not Available |
Full Name | Ms Susan Darnell Turner Iv |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 256 School Street, Betsy Layne, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417161787 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | KY-1170 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Susan Darnell Turner Iv, Po Box 756, Staffordsville, KY 41256-0756 Ph: (606) 478-9751 | Ms Susan Darnell Turner Iv, 256 School Street, Betsy Layne, KY 41605-0128 Ph: (606) 478-9751 |
News Archive
In a paper recently uploaded to the preprint server medRxiv by Edward Málaga Trillo et al. (April 29th, 2021), these methods are tested in combination with CRISPR-Cas detection in the field, demonstrating a sensitivity and specificity of 93.8% and 99%, respectively.
If you have two faulty copies of the CFTR gene, you will have cystic fibrosis. But the severity of your disease will depend on environmental factors and many other genes. Locating these genes and altering their function could lead to new therapies.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted it an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Schering Plough's Clarinex® tablets, 5 mg.
› Verified 4 days ago